United States set
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human Liver FABP (FABP1) ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:FABP1, fatty acid binding protein 1, liver fatty acid binding protein, FABPL
  • Species:Human
Cat. No. Size Price

RHK404-02R 2x96 wells (1 kit) $1225
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Urine, Plasma, Cell culture supernatant

Sample Requirements

10 µl/well


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Range

102-25,000 pg/ml

Limit of Detection

102 pg/ml



The total assay time is 3.5 hours

The kit measures L-FABP in human serum, plasma, urine, cell curlture supernatant

Assay format is 96 wells

Components of the kit are provided ready to use or concentrated

Research topic

Energy metabolism and body weight regulation, Renal disease


Fatty acid-binding proteins (FABPs) are a class of cytoplasmic proteins that bind long chain fatty acids. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas. Liver-type fatty acid binding protein (L-FABP, FABP1) is predominantly expressed in liver. The L‑FABP protein is derived from the human FABP1 gene. L-FABP is a sensitive marker for cell damage of liver cells in vitro and in vivo. L-FABP is also a marker for rapid hepatocyte lysis in vitro (as for example in toxicology assays) and for detection of liver damage during and after transplantation. Serum/plasma and urine of healthy individuals contains approximately 12 ng/ml and 16 ng/ml.

Related Products Docs